Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Jun 1 2022

Strategic Partnerships Between Early-Stage Therapeutic Ventures and Industry: Negotiating Term Sheets

June 1, 2022

2:30 PM - 3:30 PM


Virtual at Cure


In recent years, venture funding has hit new heights which were driven by lofty step-ups in valuations and fast M&A and IPO activity.  New venture funds allocated to healthcare, have almost doubled 2020’s record, providing a larger pool of focused capital to support new investments in the future healthcare ecosystem.  This funding growth presents lots of opportunities for companies seeking venture funding.

Initiating a collaborative partnership between large pharma and a startup can increase the likelihood of funding and an eventual exit. During this robust discussion, we will highlight the structure of an optimal term sheet with a particular focus on:

  • Optimized upfront payments
  • Milestones pre/post commercial sale
  • Royalty Structuring

Designed for executives and management interested in understanding term sheet negotiations

In Partnership with Silicon Valley Bank

Click here for more details



Date posted

May 13, 2022

Date updated

May 13, 2022